Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2825.05 | 245 / 245 | 100% | 111.39 | 502 / 502 |
stomach | 100% | 1015.23 | 358 / 359 | 100% | 18.98 | 285 / 286 |
breast | 100% | 1387.11 | 459 / 459 | 99% | 24.17 | 1107 / 1118 |
intestine | 100% | 2361.27 | 965 / 966 | 99% | 20.26 | 522 / 527 |
thymus | 100% | 1343.40 | 653 / 653 | 98% | 13.86 | 592 / 605 |
lung | 100% | 1347.73 | 576 / 578 | 97% | 14.23 | 1117 / 1155 |
kidney | 99% | 1189.96 | 88 / 89 | 97% | 19.86 | 874 / 901 |
bladder | 100% | 959.81 | 21 / 21 | 94% | 15.34 | 474 / 504 |
uterus | 100% | 1100.53 | 170 / 170 | 91% | 12.37 | 418 / 459 |
esophagus | 100% | 1029.79 | 1444 / 1445 | 88% | 10.38 | 161 / 183 |
liver | 100% | 1455.71 | 226 / 226 | 87% | 11.58 | 352 / 406 |
skin | 100% | 1250.70 | 1809 / 1809 | 83% | 11.22 | 393 / 472 |
adrenal gland | 95% | 608.26 | 245 / 258 | 87% | 21.36 | 200 / 230 |
brain | 97% | 723.59 | 2560 / 2642 | 84% | 8.21 | 595 / 705 |
pancreas | 80% | 342.67 | 261 / 328 | 99% | 17.11 | 176 / 178 |
ovary | 93% | 549.79 | 168 / 180 | 83% | 9.23 | 355 / 430 |
adipose | 100% | 1317.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1517.12 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.96 | 29 / 29 |
spleen | 100% | 3567.80 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1660.75 | 912 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 13.42 | 44 / 45 |
heart | 95% | 679.28 | 819 / 861 | 0% | 0 | 0 / 0 |
muscle | 75% | 277.95 | 606 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 61% | 5.53 | 49 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006670 | Biological process | sphingosine metabolic process |
GO_0070291 | Biological process | N-acylethanolamine metabolic process |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0070292 | Biological process | N-acylphosphatidylethanolamine metabolic process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0017040 | Molecular function | N-acylsphingosine amidohydrolase activity |
GO_0047412 | Molecular function | N-(long-chain-acyl)ethanolamine deacylase activity |
GO_0016810 | Molecular function | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0102121 | Molecular function | ceramidase activity |
GO_0017064 | Molecular function | fatty acid amide hydrolase activity |
Gene name | NAAA |
Protein name | N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.60) (Acid ceramidase-like protein) (Acylsphingosine deacylase NAAA) (EC 3.5.1.23) (N-acylsphingosine amidohydrolase-like) (ASAH-like protein) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta] N-acylethanolamine acid amidase (cDNA FLJ54891, highly similar to N-acylethanolamine-hydrolyzing acid amidase) N-acylethanolamine acid amidase |
Synonyms | PLT ASAHL |
Description | FUNCTION: Degrades bioactive fatty acid amides to their corresponding acids, with the following preference: N-palmitoylethanolamine > N-myristoylethanolamine > N-lauroylethanolamine = N-stearoylethanolamine > N-arachidonoylethanolamine > N-oleoylethanolamine . Also exhibits weak hydrolytic activity against the ceramides N-lauroylsphingosine and N-palmitoylsphingosine . . |
Accessions | D6R9S9 ENST00000286733.9 [Q02083-1] ENST00000505594.1 B4DVL2 R4GNC0 ENST00000513045.6 Q02083 H0Y988 ENST00000602782.5 ENST00000507187.2 ENST00000507956.5 [Q02083-2] |